Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Vertical Diplopia
Semin Neurol 20:21-30, Acierno,M.D., 2000
Treatment of Ocular Myasthenia
Arch Neurol 57:752-753, Kaminski,H.J.&Daroff,R.B., 2000
Treatment of Ocular Myasthenia With Corticosteroids
Arch Neurol 57:750-751,753, Agius,M.A., 2000
Clinicopath Conf.,Myasthenia Gravis with Thymoma, Case 15-2000
NEJM 342:1508-1514, , 2000
Retrospective Analysis of the Use of Cyclosporine in Myasthenia Gravis
Neurol 55:448-450, Ciafaloni,E. et al, 2000
Practice Parameter: Thymectomy for Autoimmune Myasthenia Gravis (an Evidence-based Review)
Neurol 55:7-15,3, Gronseth,G.S. & Barohn,R.J., 2000
Pressure-Controlled Ventilation Via a Mini-Tracheostomy Tube for Patients with Neuromuscular Disease
Neurol 55:698-702,613,615, 611, Nomori,H. & Ishihara,T., 2000
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Disorientation and Vertebral Fractures
Lancet 353:1848, McConnaughey,D.,et al, 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Neuroendocrine Lung Tumors and Disorders of the Neuromuscular Junction
Neurol 52:1490-1491, Burns,T.M.,et al, 1999
Paraneoplastic Syndromes
Arch Neurol 56:405-408, Dalmau,J.O.&Posner,J.B., 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999
Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Int Med 159:281-284, Ben-Ami,H.,et al, 1999
Achalasia and Myasthenia Gravis in a Patient with Thymoma
Neurol 52:425-426, Kaminski,H.J., 1999
Plasma Exchange Versus Intravenous Immunoglobulin Treatment in Myasthenic Crisis
Neurol 52:629-632, Qureshi,A.I.,et al, 1999
Late-Onset Myasthenia Graivs,A Changing Scene
Arch Neurol 56:25-27, Aarli,J.A., 1999
Course and Treatment of Myasthenia Gravis During Pregnancy
Neurol 52:447-452, Batocchi,A.P.,et al, 1999
Hemiballismus-Hemochorea in Older Diabetic Women:A Clinical Syndrome with MRI Correlation
Neurol 52:646-648, Lee,B-C.,et al, 1999
Distal Myasthenic Gravis
Neurol 52:632-634, Nations,S.P.,et al, 1999
Binocular Vertical Diplopia
Mayo Clin Proc 73:55-66, Brazis,P.W.&Lee,A.G., 1998
The Long-Term Clinical Outcome of Myasthenia Gravis in Patients with Thymoma
Neurol 51:1198-1200, Bril,V.,et al, 1998
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Fluoroquinolone Antibiotics Block Neuromuscular Transmission
Neurol 50:804-807, Sieb,J.P., 1998
Acetylcholine Receptor Antibodies in the Lambert-Eaton Myasthenic Syndrome
Neurol 50:470-475, Katz,J.S.,et al, 1998
HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998
Myasthenic Hand
Neurol 51:913-914, Janssen,J.C.,et al, 1998
Successful Treatment of a Patient with Severe Refractory Myasthenia Gravis Using Mycophenolate Mofetil
Neurol 51:912-913, Hauser,R.A.,et al, 1998
Neurologic Emergencies in Cancer Patients
Neurol Clin 16:1-37, Schiff,D.,et al, 1998
Respiratory Management in Acute Neurologic Illness
Neurol 50:11-20, Wijdicks,E.F.M.&Borel,C.O., 1998
Postpartum Coma
Lancet 351:1700, McCormack,G.,et al, 1998
A Randomized Double-Blind Trial of Prednisolone Alone or with Azathioprine in Myasthenia Gravis
Neurol 50:1778-1783, Palace,J.,et al, 1998
Myasthenia gravis Presenting as Isolated Respiratory Failure
Nihon Kokyuki Gakkai Zasshi 36:891-895, Kishimoto,N., 1998
Neuroimagen en la hipoglucemia
Rev Neurol 26:774-776, Cubo,E.,et al, 1998
Recovery From Myasthenic Crisis After Use of IVIG Therapy
Indian Pediatrics 35:901-903, Jain,K.,et al, 1998
Acquired Myasthenia Gravis
Neurol Clin 15:578, Massey,J.M., 1997
Specific Changes in Human Brain After Hypoglycemic Injury
Stroke 28:584-587, Fujioka,M.,et al, 1997
Acute Respiratory Insufficiency Revealing Myasthenia gravis: A Propos of 3 Cases
Arch Pediatr 4:845-848, Vodoff,M.V., 1997
The Clinical Limits of Myasthenia Gravis and Differential Diagnosis
Neurol 48 (Suppl 5) :S36-S39997., Lisak,R.P., 1997
Thymectomy for Myasthenia Gravis
Neurol 48 (Suppl 5) :S52-S63997., Jaretzki,A., 1997
Treatment of Hepatic Encephalopathy
NEJM 337:473-479, Riordan,S.M.,et al, 1997
Clinical Trial of Plasma Exchange and High-dose Intravenous Immunoglobulin in Myasthenia Gravis
Ann Neurol 41:789-796, Gajdos,P.,et al, 1997
Intensive Care of the Myasthenic Patient
Neurol 48 (Suppl 5) :S70-S75997., Mayer,S.A., 1997
Myasthenic Crisis:Clinical Features, Mortality, Comp, & Risk Factors for Prolonged Intubation
Neurol 48:1253-1254, Thomas,C.E.,et al, 1997